{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:46:40Z","timestamp":1769107600764,"version":"3.49.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":939,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We witnessed major advances in the management of heart failure (HF) in 2022. Results of recent clinical and preclinical investigations aid preventive strategies, diagnostic efforts, and therapeutic interventions, and collectively, they hold promises for a more effective HF care for the near future. Accordingly, currently available information extends the 2021 European Society of Cardiology guidelines and provides a solid background for the introduction of improved clinical approaches in the number of HF-related cases. Elaboration on the relationships between epidemiological data and risk factors lead to better understanding of the pathophysiology of HF with reduced ejection fraction and HF with preserved ejection fraction. The clinical consequences of valvular dysfunctions are increasingly interpreted not only in their haemodynamic consequences but also in association with their pathogenetic factors and modern corrective treatment possibilities. The influence of coronavirus disease 2019 pandemic on the clinical care of HF appeared to be less intense in 2022 than before; hence, this period allowed to refine coronavirus disease 2019 management options for HF patients. Moreover, cardio-oncology emerges as a new subdiscipline providing significant improvements in clinical outcomes for oncology patients. Furthermore, the introduction of state-of-the-art molecular biologic methods, multi-omic approaches forecast improved phenotyping and precision medicine for HF. All above aspects are addressed in this article that highlights a selection of papers published in ESC Heart Failure in 2022.<\/jats:p>","DOI":"10.1002\/ehf2.14377","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T23:13:35Z","timestamp":1681859615000},"page":"2150-2158","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Year in Heart Failure: Updates of Clinical and Preclinical Findings"],"prefix":"10.1093","volume":"10","author":[{"given":"Magnus","family":"B\u00e4ck","sequence":"first","affiliation":[{"name":"Translational Cardiology, Center for Molecular Medicine, Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Institut National de laSante et de la Recherche Medicale U1116, Universit\u00e9 de Lorraine , Nancy ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University of G\u00f6ttingen Medical Center , G\u00f6ttingen ,","place":["Germany"]},{"name":"German Center for Cardiovascular Research (DZHK), Partner Site G\u00f6ttingen , G\u00f6ttingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4675-1542","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Papp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Division of Clinical Physiology, Faculty of Medicine, University of Debrecen , Debrecen ,","place":["Hungary"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo F.","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Clinical Cardiology, IRCCS Policlinico San Donato , S. Donato Milanese, Milan, 20097 ,","place":["Italy"]},{"name":"Department of Preventive Cardiology, Wroclaw Medical University , Wroc\u0142aw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"2026012114084358700_ehf214377-bib-0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114084358700_ehf214377-bib-0002","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1002\/ehf2.13429","article-title":"Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction","volume":"8","author":"Gaziano","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0003","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1002\/ehf2.13476","article-title":"Identification of sex-specific biomarkers predicting new-onset heart failure","volume":"8","author":"Raafs","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0004","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/ehf2.14076","article-title":"Impact analysis of heart failure across European countries: an ESC-HFA position paper","volume":"9","author":"Rosano","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0005","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/ehf2.13921","article-title":"Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort","volume":"9","author":"Chen","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0006","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/ehf2.13365","article-title":"Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications","volume":"8","author":"Bikiewicz","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0007","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ehf2.13879","article-title":"Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients","volume":"9","author":"Cuomo","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0008","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/ehf2.13510","article-title":"Use of novel non-invasive techniques and biomarkers to guide outpatient management of fluid overload and reduce hospital readmission: systematic review and meta-analysis","volume":"8","author":"Zisis","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0009","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/ehf2.13444","article-title":"Sex-specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients","volume":"8","author":"van der Lingen","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0010","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1002\/ehf2.13506","article-title":"Preventive implantable cardioverter defibrillator therapy in contemporary clinical practice: need for more stringent selection criteria","volume":"8","author":"Deckers","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0011","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/ehf2.13531","article-title":"Prognostic factors of Takotsubo cardiomyopathy: a systematic review","volume":"8","author":"Lu","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0012","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1002\/ehf2.13584","article-title":"Factors associated with lack of improvement in submaximal exercise capacity of patients with heart failure","volume":"8","author":"Jaarsma","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0013","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/ehf2.14070","article-title":"Peak O2-pulse predicts exercise training-induced changes in peak V\u0307O2 in heart failure with preserved ejection fraction","volume":"9","author":"Mueller","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0014","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/ehf2.14032","article-title":"Impact of different training modalities on high-density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial","volume":"9","author":"Sowa","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0015","first-page":"2808","volume-title":"A clinical consensus statement from the ESC Council for Cardiology Practice\/Taskforce on Geriatric Cardiology, the ESC Digital Health Committee and the ESC Working Group on e-Cardiology","author":"Guasti","year":"2022"},{"key":"2026012114084358700_ehf214377-bib-0016","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/ehf2.13934","article-title":"Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty","volume":"9","author":"Nagatomi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0017","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/ehf2.13759","article-title":"Characteristics and outcomes of patients admitted for acute heart failure in a single-centre study","volume":"9","author":"Dokoupil","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0018","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/ehf2.14096","article-title":"Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry","volume":"9","author":"Harikrishnan","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0019","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ehf2.14162","article-title":"Aetiology of chronic heart failure in patients from a super-aged society: the KUNIUMI registry chronic cohort","volume":"10","author":"Fujimoto","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0020","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/ehf2.14118","article-title":"Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas","volume":"9","author":"Palazzuoli","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ehf2.14192","article-title":"Systemic blood pressure in severe aortic stenosis: haemodynamic correlates and long-term prognostic impact","volume":"10","author":"Maeder","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0022","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ehf2.13846","article-title":"Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis","volume":"9","author":"Graziani","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0023","doi-asserted-by":"crossref","first-page":"oeac074","DOI":"10.1093\/ehjopen\/oeac074","article-title":"Characterization of myocardial mechanics and its prognostic significance in patients with severe aortic stenosis undergoing aortic valve replacement","volume":"2","author":"Bi","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2026012114084358700_ehf214377-bib-0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/VHRM.S358741","article-title":"Arterial stiffness in aortic stenosis and the impact of aortic valve replacement","volume":"18","author":"Plunde","year":"2022","journal-title":"Vasc Health Risk Manag"},{"key":"2026012114084358700_ehf214377-bib-0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.754371","article-title":"Cardiovascular risk factors and hemodynamic measures as determinants of increased arterial stiffness following surgical aortic valve replacement","volume":"8","author":"Plunde","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026012114084358700_ehf214377-bib-0026","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012114084358700_ehf214377-bib-0027","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/ehf2.13774","article-title":"HFA-PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation","volume":"9","author":"Seoudy","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0028","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/ehf2.13946","article-title":"Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease","volume":"9","author":"Onishi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0029","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1002\/ehf2.13772","article-title":"Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis","volume":"9","author":"Chiarito","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ehf2.13849","article-title":"One-year results following PASCAL-based or MitraClip-based mitral valve transcatheter edge-to-edge repair","volume":"9","author":"Geis","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0031","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ehf2.14196","article-title":"Impact of improving severity of secondary mitral regurgitation on survival","volume":"10","author":"Sannino","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0032","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ehf2.14160","article-title":"Metabolomics implicate eicosanoids in severe functional mitral regurgitation","volume":"10","author":"Hofbauer","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0033","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","article-title":"Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke","volume":"33","author":"Capra","year":"2013","journal-title":"Med Res Rev"},{"key":"2026012114084358700_ehf214377-bib-0034","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2026012114084358700_ehf214377-bib-0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.plefa.2013.04.001","article-title":"Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men","volume":"89","author":"Schuchardt","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2026012114084358700_ehf214377-bib-0036","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.895","article-title":"Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: a single-blind randomized controlled trial","volume":"12","author":"Arnardottir","year":"2022","journal-title":"Clin Transl Med"},{"key":"2026012114084358700_ehf214377-bib-0037","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/eurheartj\/ehab679","article-title":"TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery","volume":"43","author":"Dreyfus","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012114084358700_ehf214377-bib-0038","doi-asserted-by":"crossref","first-page":"oeac067","DOI":"10.1093\/ehjopen\/oeac067","article-title":"A validated score to predict one-year and long-term mortality in patients with significant tricuspid regurgitation","volume":"2","author":"Hochstadt","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2026012114084358700_ehf214377-bib-0039","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ehf2.13831","article-title":"Functional improvement following direct interventional leaflet repair of severe tricuspid regurgitation","volume":"9","author":"Volz","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ehf2.13805","article-title":"Sodium-glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta-analysis","volume":"9","author":"Pandey","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0041","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/ehf2.13241","article-title":"Meta-analysis of the effects of four factors on the efficacy of SGLT2 inhibitors in patients with HFrEF","volume":"8","author":"Qiu","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0042","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1002\/ehf2.13615","article-title":"Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial","volume":"8","author":"Fitchett","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0043","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1002\/ehf2.13645","article-title":"SGLT2 inhibitors and cardiac remodelling: a systematic review and meta-analysis of randomized cardiac magnetic resonance imaging trials","volume":"8","author":"Dhingra","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0044","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1002\/ehf2.13622","article-title":"Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure","volume":"8","author":"Kolwelter","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ehf2.14186","article-title":"Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction","volume":"10","author":"Ortega-Paz","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0046","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ehf2.13265","article-title":"Iron deficiency in heart failure","volume":"8","author":"Loncar","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0047","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/ehf2.13204","article-title":"Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction","volume":"8","author":"Barandiar\u00e1n Aizpurua","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0048","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0049","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/ehf2.13245","article-title":"Diagnosis and treatment of iron deficiency in heart failure: OFICSel study by the French Heart Failure Working Group","volume":"8","author":"Pezel","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ehf2.14177","article-title":"Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency","volume":"10","author":"Sindone","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0051","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2023","journal-title":"Lancet"},{"key":"2026012114084358700_ehf214377-bib-0052","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ehf2.13753","article-title":"Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction","volume":"9","author":"L\u00f3pez-Vilella","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0053","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1002\/ehf2.14050","article-title":"Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial","volume":"9","author":"Senni","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0054","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/ehf2.13837","article-title":"Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction","volume":"9","author":"Oh","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ehf2.13768","article-title":"Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine","volume":"9","author":"Zhu","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0056","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/ehf2.13939","article-title":"Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy","volume":"9","author":"Hnat","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0057","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/ehf2.14003","article-title":"Uncovering the genetic links of SARS-CoV-2 infections on heart failure co-morbidity by a systems biology approach","volume":"9","author":"Zhang","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0058","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/ehf2.14026","article-title":"Pharmacogenomic study of heart failure and candesartan response from the CHARM programme","volume":"9","author":"Dub\u00e9","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0059","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/ehf2.14034","article-title":"Histopathological and epigenetic changes in myocardium associated with cancer therapy-related cardiac dysfunction","volume":"9","author":"Terada","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0060","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/ehf2.14048","article-title":"Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension","volume":"9","author":"Zhou","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0061","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/ehf2.13919","article-title":"Serum microRNAs are key predictors of long-term heart failure and cardiovascular death after myocardial infarction","volume":"9","author":"Rinc\u00f3n","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0062","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/ehf2.14059","article-title":"Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy","volume":"9","author":"Fujita","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0063","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1002\/ehf2.14116","article-title":"Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF","volume":"9","author":"Piatek","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0064","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/ehf2.14120","article-title":"Insulin-like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence","volume":"9","author":"Bracun","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ehf2.13845","article-title":"Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis","volume":"9","author":"Pappritz","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0066","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ehf2.13796","article-title":"The novel proteomic signature for cardiac allograft vasculopathy","volume":"9","author":"Wei","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084358700_ehf214377-bib-0067","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/ehf2.13832","article-title":"Mechanosensitive molecular mechanisms of myocardial fibrosis in living myocardial slices","volume":"9","author":"Nunez-Toldra","year":"2022","journal-title":"ESC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2150\/64704661\/eschf_10_4_2150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2150\/64704661\/eschf_10_4_2150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:09:22Z","timestamp":1769022562000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/4\/2150\/8285292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,18]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14377","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"2023-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}